B I09

Mfr.No.	T14847
Description	B I09, an IRE-1 RNase inhibitor with an IC50 of 1230 nM, inhibits splicing of XBP1 mRNA in human WaC3 cells and expression of xbp-1 in LPS-stimulated B cells. B I09 can be used to simulate the defects of XBP-1 in CLL cells., an IRE-1 RNase inhibitor with an IC50 of 1230 nM, inhibits splicing of XBP1 mRNA in human WaC3 cells and expression of xbp-1 in LPS-stimulated B cells. B I09 can be used to simulate the defects of XBP-1 in CLL cells., an IRE-1 RNase inhibitor with an IC50 of 1230 nM, inhibits splicing of XBP1 mRNA in human WaC3 cells and expression of xbp-1 in LPS-stimulated B cells. B I09 can be used to simulate the defects of XBP-1 in CLL cells.
Molecular Formula	C16H17NO5
Signaling Pathways	Cell Cycle/Checkpoint, Others
Smiles	OC=1C(=C2C(C3=C(C(=O)O2)CNCC3)=CC1)C4OCCCO4
Cas Number	1607803-67-7
Molecular Weight	303.31
Target	Others, IRE1

Have you used this product?

SKU	Supplier No.	Size	Your price
BHB20408021	T14847	1 mg	$44	Add to Cart
BHB20408021	T14847	5 mg	$98	Add to Cart
BHB20408021	T14847	10 mg	$163	Add to Cart
BHB20408021	T14847	25 mg	$268	Add to Cart
BHB20408021	T14847	50 mg	$396	Add to Cart
BHB20408021	T14847	100 mg	$562	Add to Cart